It's true. We are recruiting. Join us!

so exciting to see our origin story in print!

TrPR’s @UCSF_AndrewPenn spoke in the Psychedelic Revival series from @PennNursing! Andrew discusses preparation for therapy, what occurs during a therapy session, and the meaning of integration. Check it out at youtube.com/watch?v=TfraYldV….

@UCSF_AndrewPenn at TrPR was recently interviewed by Psychedelics Today! Check out the podcast at psychedelicstoday.com/2022/0…!

(4/4) Reconsider and Horizon also produced a feature-length documentary on psychedelics in the veteran community, which Zach is featured in. Check it out at vimeo.com/646708536! #TrPR

(1/7) TrPR is excited to announce our recent publication led by @AvronLeehe and @thebandlab, Understanding others through observed touch: neural correlates, developmental aspects, and psychopathology. Check out the study at authors.elsevier.com/a/1e2br…!

(2/2) On the podcast, Dr. Woolley discussed psilocin, the active metabolite of psilocybin, an ingredient in magic mushrooms. He explored the differences between psilocin and psilocybin, and the potential for creating psychedelic medicines.

We are hiring a clinical research coordinator to work on clinical trials of psilocybin and related compounds. Come join our team! jobs.brassring.com/TGnewUI/S…

Two major thematic change processes were identified: 1) participants reported transitioning out of habitual, evaluative modes of processing and into mindful, experiential modes of processing (from “autopilot” to “meta-aware”). Freed from their emotionally avoidant tendencies,

We focused on a sub-sample (n = 9) who had clinically significant trauma symptoms. Microphenomenological interviews were carried out 1 day after participants’ individual psilocybin sessions to elicit fine-grained descriptions of the psilocybin-assisted treatment.